• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有多种慢性病和多种药物治疗的门诊老年患者的药物相关生活质量 (MRQoL)。

Medication-related quality of life (MRQoL) in ambulatory older adults with multi-morbidity and polypharmacy.

机构信息

Department of Medicine (Geriatric Medicine), University College Cork, Wilton, T12 DC4A, Cork, Ireland.

Department of Geriatric Medicine, Cork University Hospital, Wilton, Cork, Ireland.

出版信息

Eur Geriatr Med. 2022 Jun;13(3):579-583. doi: 10.1007/s41999-021-00573-6. Epub 2021 Oct 21.

DOI:10.1007/s41999-021-00573-6
PMID:34676497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9151516/
Abstract

PURPOSE

To assess medication-related quality-of-life (MRQoL) in multi-morbid older adults with polypharmacy and correlations with medications, frailty and health-related QoL.

METHODS

With a cross sectional study of multi-morbid geriatric medicine outpatients, we assessed MRQoL (MRQol-LSv1), frailty status, potentially inappropriate medications, Medication Adherence Rating Scale (MARS), health-related-QoL (Short-Form 12, SF12) and medication burden (Living with Medicines Questionnaire, LMQv2).

RESULTS

One-in-four (n = 59) of 234 outpatient attendees met inclusion criteria. Almost half (n = 106, 45%) were excluded due to cognition (MMSE < 26). Included participants (n = 27, mean age 80.2 years) experienced a median of 11 (IQR 9-13.5) co-morbidities and were prescribed a median of 10 (IQR 8-12.25) medications. Overall, MRQoL-LS.v.1 scores were low, suggesting good medication-related quality of life (median MRQoL-LS.v.1 score of 14, IQR 14-22). Correlations between MRQoL, number of daily medications, co-morbidity burden, LMQv2 score, SF12 scores and number of PIMs were non-significant.

CONCLUSION

MRQoL-LSv.1 is unsuitable for most patients attending geriatric ambulatory services.

摘要

目的

评估患有多种疾病且服用多种药物的老年患者的药物相关生活质量(MRQoL)与药物、虚弱和健康相关生活质量的相关性。

方法

采用多病态老年医学门诊患者的横断面研究,评估 MRQoL(MRQol-LSv1)、虚弱状况、潜在不适当药物、药物依从性评定量表(MARS)、健康相关生活质量(SF12)和药物负担(用药生活质量问卷,LMQv2)。

结果

234 名门诊患者中,有 1/4(n=59)符合纳入标准。由于认知功能(MMSE<26),近一半(n=106,45%)患者被排除在外。纳入的患者(n=27,平均年龄 80.2 岁)患有 11 种(IQR 9-13.5)共病,平均服用 10 种(IQR 8-12.25)药物。总体而言,MRQoL-LS.v.1 评分较低,表明药物相关生活质量良好(MRQoL-LS.v.1 评分中位数为 14,IQR 14-22)。MRQoL 与每日用药数量、共病负担、LMQv2 评分、SF12 评分和 PIM 数量之间的相关性均无统计学意义。

结论

MRQoL-LSv.1 不适用于大多数接受老年门诊服务的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/9151516/8f460de733f5/41999_2021_573_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/9151516/8f460de733f5/41999_2021_573_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/9151516/8f460de733f5/41999_2021_573_Fig1_HTML.jpg

相似文献

1
Medication-related quality of life (MRQoL) in ambulatory older adults with multi-morbidity and polypharmacy.患有多种慢性病和多种药物治疗的门诊老年患者的药物相关生活质量 (MRQoL)。
Eur Geriatr Med. 2022 Jun;13(3):579-583. doi: 10.1007/s41999-021-00573-6. Epub 2021 Oct 21.
2
Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital.多药治疗的埃塞俄比亚老年患者的药物相关生活质量:埃塞俄比亚大学医院的一项横断面研究。
PLoS One. 2019 Mar 28;14(3):e0214191. doi: 10.1371/journal.pone.0214191. eCollection 2019.
3
Potentially Inappropriate Medications and Polypharmacy: A Study of Older People with Mild Cognitive Impairment and Mild Dementia.潜在不适当药物和多种药物治疗:轻度认知障碍和轻度痴呆老年人的研究。
J Alzheimers Dis. 2019;71(3):889-897. doi: 10.3233/JAD-190284.
4
Translation and psychometric validation of a Danish version of the medication-related quality of life scale.丹麦版药物相关生活质量量表的翻译及心理测量学验证。
Int J Clin Pharm. 2020 Apr;42(2):667-676. doi: 10.1007/s11096-020-00979-5. Epub 2020 Feb 5.
5
Prevalence of polypharmacy and medication-related quality of life among adult patients in Al-Ahsa, Saudi Arabia.沙特阿拉伯阿哈萨的成年患者中多药治疗的流行情况和与药物相关的生活质量。
J Med Life. 2023 Sep;16(9):1415-1420. doi: 10.25122/jml-2023-0101.
6
Improving individualized prescription in patients with multimorbidity through medication review.通过药物审查改善多病共存患者的个体化处方。
BMC Geriatr. 2022 May 12;22(1):417. doi: 10.1186/s12877-022-03107-2.
7
Investigating Frailty, Polypharmacy, Malnutrition, Chronic Conditions, and Quality of Life in Older Adults: Large Population-Based Study.调查老年人虚弱、多种药物治疗、营养不良、慢性疾病和生活质量:基于大人群的研究。
JMIR Public Health Surveill. 2024 Oct 11;10:e50617. doi: 10.2196/50617.
8
Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study.社区居住的患有多种疾病和多种药物治疗的老年患者自我报告药物依从性的风险因素:一项多中心横断面研究。
BMC Geriatr. 2023 Feb 6;23(1):75. doi: 10.1186/s12877-023-03768-7.
9
Developing a measure of medication-related quality of life for people with polypharmacy.为多重用药患者制定药物相关生活质量的衡量标准。
Qual Life Res. 2016 May;25(5):1295-302. doi: 10.1007/s11136-015-1177-2. Epub 2015 Nov 19.
10
Effectiveness of an Integrated Ambulatory Care Program in Health Care and Medication Use in Patients With Multimorbidity and Polypharmacy.综合性门诊护理计划对多病共存和多重用药患者的医疗保健和药物使用的效果。
Qual Manag Health Care. 2024;33(1):18-28. doi: 10.1097/QMH.0000000000000434. Epub 2023 Sep 20.

引用本文的文献

1
Medication-related Burden and Experience With Medications in Indonesian Older Adults With Chronic Diseases: A Mixed-method Study.印度尼西亚慢性病老年患者的药物相关负担及用药体验:一项混合方法研究
J Prev Med Public Health. 2025 Mar;58(2):188-198. doi: 10.3961/jpmph.24.374. Epub 2024 Nov 20.
2
The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy.多病共存的老年患者多重用药情况下药物使用与健康相关生活质量之间的关联。
Eur Geriatr Med. 2024 Dec;15(6):1713-1723. doi: 10.1007/s41999-024-01036-4. Epub 2024 Aug 20.
3
Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study.

本文引用的文献

1
Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis.潜在不适当处方及其与住院老年患者健康相关和系统相关结局的关联:系统评价和荟萃分析。
Br J Clin Pharmacol. 2021 Nov;87(11):4150-4172. doi: 10.1111/bcp.14870. Epub 2021 May 18.
2
Factors Associated with Health-Related Quality of Life in Community-Dwelling Older Adults: A Multinomial Logistic Analysis.社区居住老年人健康相关生活质量的影响因素:多项逻辑回归分析
J Clin Med. 2019 Nov 1;8(11):1810. doi: 10.3390/jcm8111810.
3
Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).
选择用于核心结局集的结局测量工具,以改善初级保健中老年人群中适当的多药治疗:一项德尔菲共识研究。
Int J Clin Pharm. 2024 Dec;46(6):1391-1399. doi: 10.1007/s11096-024-01780-4. Epub 2024 Jul 23.
4
Measuring Quality of Life in Deprescribing Trials: A Scoping Review.测量减药试验中的生活质量:范围综述。
Drugs Aging. 2024 May;41(5):379-397. doi: 10.1007/s40266-024-01113-0. Epub 2024 May 6.
5
Prevalence of polypharmacy and medication-related quality of life among adult patients in Al-Ahsa, Saudi Arabia.沙特阿拉伯阿哈萨的成年患者中多药治疗的流行情况和与药物相关的生活质量。
J Med Life. 2023 Sep;16(9):1415-1420. doi: 10.25122/jml-2023-0101.
6
Interventions to improve the appropriate use of polypharmacy for older people.干预措施以改善老年人的药物合用(polypharmacy)的合理使用。
Cochrane Database Syst Rev. 2023 Oct 11;10(10):CD008165. doi: 10.1002/14651858.CD008165.pub5.
7
Correlation between the number of patient-reported adverse events, adverse drug events, and quality of life in older patients: an observational study.老年患者报告的不良事件、药物不良事件与生活质量之间的相关性:一项观察性研究。
Int J Clin Pharm. 2022 Dec;44(6):1434-1441. doi: 10.1007/s11096-022-01481-w. Epub 2022 Oct 15.
聚焦于个人目标、生活质量和多重用药老年人健康问题的临床药物治疗评估对其影响:一项随机对照试验(DREAMeR 研究)。
PLoS Med. 2019 May 8;16(5):e1002798. doi: 10.1371/journal.pmed.1002798. eCollection 2019 May.
4
Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital.多药治疗的埃塞俄比亚老年患者的药物相关生活质量:埃塞俄比亚大学医院的一项横断面研究。
PLoS One. 2019 Mar 28;14(3):e0214191. doi: 10.1371/journal.pone.0214191. eCollection 2019.
5
Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial.一项综合干预措施对基层医疗中多重疾病患者多重用药优先排序(PRIMUM)的效果:一项实用整群随机对照试验的结果
BMJ Open. 2018 Feb 24;8(2):e017740. doi: 10.1136/bmjopen-2017-017740.
6
Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter?过去25年的药学服务与健康相关生活质量结果:我们所测量的维度真的重要吗?
Int J Clin Pharm. 2018 Feb;40(1):3-14. doi: 10.1007/s11096-017-0582-8. Epub 2018 Jan 10.
7
Validation of an instrument to measure patients' experiences of medicine use: the Living with Medicines Questionnaire.一种用于衡量患者用药体验的工具的验证:《药物治疗生活问卷》
Patient Prefer Adherence. 2017 Mar 28;11:671-679. doi: 10.2147/PPA.S126647. eCollection 2017.
8
Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review.改善老年人合理使用多种药物的干预措施:一项Cochrane系统评价
BMJ Open. 2015 Dec 9;5(12):e009235. doi: 10.1136/bmjopen-2015-009235.
9
Developing a measure of medication-related quality of life for people with polypharmacy.为多重用药患者制定药物相关生活质量的衡量标准。
Qual Life Res. 2016 May;25(5):1295-302. doi: 10.1007/s11136-015-1177-2. Epub 2015 Nov 19.
10
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.老年人潜在不适当处方的STOPP/START标准:第2版
Age Ageing. 2015 Mar;44(2):213-8. doi: 10.1093/ageing/afu145. Epub 2014 Oct 16.